On June 30th, 2023, the National Cancer Institute awarded Dr. Lund and Dr. Louise Henderson a 5-year R01 grant for nearly $1.8 million for the project, “Applying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screening.” Learn more about the project on NIH RePORTER.
The project will apply novel causal inference methodologies to evaluate the benefits and harms of lung cancer screening in clinical practice settings. Using data from the randomized National Lung Screening Trial, as well as real-world datasets including the National Health and Interview Survey, the Behavioral Risk Factors Surveillance Survey, a 20% nationwide sample of Medicare claims, and the North Carolina Lung Screening Registry, the study will generate real-world evidence to improve the delivery of lung cancer screening at the population level.
Other faculty and collaborators on the grant include Michael Hudgens, PhD, and Til Stürmer, MD, PhD, from the Gillings School, as well as Dan Reuland, MD, MPH, from the School of Medicine.